Directorate Change

RNS Number : 7507E

Provexis PLC

01 October 2008

 



1 October 2008 

PROVEXIS PLC

('Provexis' or the 'Company')

Directorate Change

Provexis plc, the life-science business that discovers, develops and licenses scientifically-proven functional food, medical food and dietary supplement technologies, is pleased to announce the appointment of Steven Morrison to its board as Chief Operating Officer with immediate effect. 

Steven Neil Morrison (43) was most recently Global Project Leader with Ipsen Limited, the French pharmaceutical business and prior to that was Director, R&D Project Management with Shire Pharmaceutical Development Limited.

Mr Morrison is interested in 1,540,000 ordinary shares of 0.1 pence each, representing 0.19 per cent of the Company's issued ordinary share capital. 

There are no further disclosures to be made in accordance with Schedule 2(g) of the AIM Rules. 

Stephen Moon, Chief Executive of Provexis plc said: 

'Steve brings 20 years of pharmaceutical industry experience and a strong track record of achievement in global product development, major project management and clinical development. I believe these capabilities will significantly accelerate all aspects of our promising portfolio, thereby enhancing shareholder value.' 

ENQUIRIES

Provexis plc                                    Tel.[phone]

Stephen Moon, Chief Executive

Ian Ford, Finance Director

Arbuthnot Securities Limited            Tel.[phone]

Tom Griffiths

Alasdair Younie

END

 

END

 

 

BOALMMATMMIJBFP